Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES

(GILD)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 30 390 26 107 22 127 22 314 22 545 22 275
EBITDA 21 191 17 317 12 840 13 083 12 387 12 059
Operating profit (EBIT) 20 033 16 031 11 411 11 591 11 225 10 779
Pre-Tax Profit (EBT) 17 097 13 529 7 799 5 249 9 287 9 590
Net income 13 501 4 628 5 455 4 273 7 101 7 294
P/E ratio 7,20x 20,4x 15,0x 17,8x 10,9x 10,7x
EPS ( $ ) 9,94 3,51 4,17 3,51 5,72 5,85
Dividend per Share ( $ ) 1,84 2,08 2,28 2,52 2,74 2,82
Yield 2,57% 2,90% 3,65% 4,03% 4,39% 4,51%
Reference price ( $ ) 71,610 71,640 62,550 62,510 62,510 62,510
Announcement Date 02/07/2017
09:01pm
02/06/2018
09:01pm
02/04/2019
09:01pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - 25 954 - 3 023 712 -
Finance 3 985 - 2 467 - - 0,00
Operating income (EBITDA) 21 191 17 317 12 840 13 083 12 387 12 059
Leverage
(Debt/EBITDA)
- 1,50x - 0,23x 0,06x -
Capital Expenditure 748 590 924 868 827 804
Book Value Per Share (BVPS) ( $ ) 14,8 15,7 16,7 18,2 19,2 19,6
Cash Flow per Share ( $ ) 12,3 9,02 6,42 6,41 7,04 7,18
Announcement Date 02/07/2017
09:01pm
02/06/2018
09:01pm
02/04/2019
09:01pm
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 79 166 M $ -
Entreprise Value (EV) 82 189 M $ 79 878 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 17,8x 10,9x
Capitalization / Revenue 3,55x 3,51x
EV / Revenue 3,68x 3,65x
EV / EBITDA 6,28x 6,64x
Yield (DPS / Price) 4,03% 4,39%
Price to book (Price / BVPS) 3,43x 3,26x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 51,9% 49,8%
Operating Leverage (Delta EBIT / Delta Sales) 1,87x -
Net Margin (Net Profit / Revenue) 19,2% 31,5%
ROA (Net Profit / Asset) 10,8% 13,3%
ROE (Net Profit / Equities) 56,9% 44,9%
Rate of Dividend 71,8% 48,0%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   3,89% 3,67%
Cash Flow / Sales 36,4% 39,5%
Capital Intensity (Assets / Sales) 1,78x 2,36x
Financial Leverage (Net Debt / EBITDA) 0,23x 0,06x
EPS & Dividend